Attitudes Towards Buprenorphine and Methadone | NCT00911846

Studies
Attitudes Towards Buprenorphine and Methadone

NCT00911846

Sponsor

Psychiatric University Hospital, Zurich

Status

Unknown status

Last Update Posted

Jun 2, 2009Estimated

Enrollment

180Estimated

Phase

Not provided

Conditions

Addictive
Opioids

Interventions

interview

Countries

Switzerland

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

May 2009

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

May 2009

Primary Completion Date

Sep 2009Estimated

Completion Date

Jun 2010Estimated

First Submitted Date

May 28, 2009

First Submission Date that Met QC Criteria

May 28, 2009

First Posted Date

Jun 2, 2009Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 28, 2009

Last Update Posted Date

Jun 2, 2009Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Main intention of this study is to find out whether there is a difference between the attitudes towards opioid- substitution of opioid dependent patients under substitution with methadone, buprenorphine or without substitution and their therapists

Detailed Description

Attitudes of patients and therapists can influence therapy success in both directions. Not much is known about patients' and their therapists' attitudes towards substitution medication. Our hypothesis is that the attitude towards buprenorphine is more positive than towards methadone even in patients taking methadone. Better knowledge about the influence of attitudes on treatment success could facilitate to adapt therapy to the patients' needs.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

180Estimated

Arms/Interventions Module

Arm Groups

Label	Description	Intervention Names
Buprenorphine	opioid-dependent patients with buprenorphine substitution	Other: interview
methadone	opioid-dependent patients substituted with methadone	Other: interview
no substitution	opioid-dependent patients without substitution	Other: interview
therapists	therapists of the patients	Other: interview

Interventions

Name	Type	Description	Arm Group Labels	Other Names
interview	Other	interview using questionnaires	Buprenorphine methadone no substitution therapists

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Attitude toward buprenorphine compared over the four groups		one time of measurement

Secondary Outcomes

Measure	Description	Time Frame
Treatment success; Treatment conditions; Consumption of substances		one point of measurement

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Age between 18 and 65 years
Opioid-dependent with substitution with buprenorphine,
methadone or without substitution
Sufficient knowledge of German language

Exclusion Criteria:

Inability to give informed consent

Accepts Healthy Volunteers

Yes

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

65 Years

Standard Ages

AdultOlder Adult

Study Population

Patients of therapeutic communities, in- and out-patients and their therapists

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Ria Leisinger, MD	Contact	0041 44 384 27 87		ria.leisinger@puk.zh.ch
Rudolf Stohler, MD	Contact	0041 44 205 58 10		rudolf.stohler@puk.zh.ch

Overall Officials

Name	Affiliation	Role
Lukas Boesch, PhD	Psychiatric University Hospital, Zurich	Study Chair

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Psychiatric University Hospital	Recruiting	Zurich	Canton of Zurich	8032	Switzerland

Intervention Browse Module

MeSH Terms

ID	Term
D007407	Interviews as Topic

Ancestor Terms

ID	Term
D003625	Data Collection
D004812	Epidemiologic Methods
D008919	Investigative Techniques
D017531	Health Care Evaluation Mechanisms

Browse Leaves

Not provided

Browse Branches

Not provided